Welcome

We are very pleased to invite you to the Association of Radiation Research meeting for 2021. As usual the meeting will include sessions covering the whole spectrum of radiation research from basic physics and chemistry through to clinical studies. It will be a great opportunity to hear from the experts and network with others in the field at the sessions and during our planned social events. Please note there will be specific support for attendance and involvement of Scientists in Training.

Speakers

Dr Muriel Brengues - Institute of Cancer Research of Montpellier

Professor Steve Jackson - Gurdon Institute, Cambridge

Dr Steve Walters - National Nuclear Laboratory Limited

Topics

Aging and radiation

Normal tissue radiobiology

Radiation chemistry

Radiation protection, environmental exposure

DNA repair

AI in radiotherapy physics

Radiobiology/physics of re-treatment

Registration

Registration will open on Monday 22 March and be available for both virtual and in person attendance, with rates offered for students, non-students, members and non-members

Registration rates will be published in due course.

In Person Attendance

We are currently hoping to offer in-person attendance on the afternoon of Tuesday 13 July including the conference dinner at Aspire. This will be subject to restrictions in place at the time of the event. Please continue to check this site for updates regarding in person attendance.

Conference Organisation

The Annual Meeting of the Association for Radiation Research 2020 is organised on behalf of ARR by Professor Susan Short.

Professor Short is a clinical oncologist with a specialist research interest in treating adults with primary brain tumours. She trained at King’s College London and took up a post as Senior Lecturer at University College London in 2004, where she ran a translational research group as CRUK Clinician Scientist and Senior Fellow. She moved to Leeds in 2012 as professor of Clinical Oncology and Neuro-Oncology and currently leads the brain cancer research section at Leeds Institute of Cancer and Pathology.